This document is an excerpt from the EUR-Lex website
Document 62014TN0202
Case T-202/14: Action brought on 28 March 2014 — LR Health & Beauty Systems/OHIM — Robert McBride (LR nova pure.)
Case T-202/14: Action brought on 28 March 2014 — LR Health & Beauty Systems/OHIM — Robert McBride (LR nova pure.)
Case T-202/14: Action brought on 28 March 2014 — LR Health & Beauty Systems/OHIM — Robert McBride (LR nova pure.)
IO C 235, 21.7.2014, p. 20–21
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
21.7.2014 |
EN |
Official Journal of the European Union |
C 235/20 |
Action brought on 28 March 2014 — LR Health & Beauty Systems/OHIM — Robert McBride (LR nova pure.)
(Case T-202/14)
2014/C 235/27
Language in which the application was lodged: English
Parties
Applicant: LR Health & Beauty Systems GmbH (Ahlen, Germany) (represented by: N. Weber and L. Thiel, lawyers)
Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs)
Other party to the proceedings before the Board of Appeal: Robert McBride Ltd (Manchester, United Kingdom)
Form of order sought
The applicant claims that the Court should:
— |
Annul the decision of the Second Board of Appeal of the Office for Harmonisation in the Internal Market (Trade Marks and Designs) of 22 January 2014 in case R 272/2013-2; |
— |
Order the defendant and, if appropriate, the other party to the proceedings to pay the costs. |
Pleas in law and main arguments
Applicant for a Community trade mark: The applicant
Community trade mark concerned: The figurative mark containing the word elements ‘LR nova pure.’ for goods in Class 3 — Community trade mark application No 9 8 51 361
Proprietor of the mark or sign cited in the opposition proceedings: The other party to the proceedings before the Board of Appeal
Mark or sign cited in opposition: International trade mark registration of the word mark NOVA
Decision of the Opposition Division: Upheld the opposition
Decision of the Board of Appeal: Dismissed the appeal
Pleas in law: Infringement of Article 8(1)(b) of Regulation No 207/2009